Free Trial

ATB Capital Cuts Canopy Growth (TSE:WEED) Price Target to C$3.20

Canopy Growth logo with Medical background

Canopy Growth (TSE:WEED - Free Report) had its price target cut by ATB Capital from C$4.00 to C$3.20 in a research note published on Monday,BayStreet.CA reports. They currently have an underperform rating on the stock.

Separately, Canaccord Genuity Group lowered their target price on shares of Canopy Growth from C$2.50 to C$1.50 and set a "sell" rating on the stock in a research note on Monday. Four investment analysts have rated the stock with a sell rating and one has assigned a hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Reduce" and a consensus price target of C$5.40.

View Our Latest Report on Canopy Growth

Canopy Growth Price Performance

WEED stock traded up C$0.12 during mid-day trading on Monday, reaching C$2.68. 1,278,250 shares of the company traded hands, compared to its average volume of 1,873,167. Canopy Growth has a 52-week low of C$2.50 and a 52-week high of C$20.50. The company has a market capitalization of C$431.13 million, a P/E ratio of -0.39, a P/E/G ratio of -0.01 and a beta of 1.79. The company has a debt-to-equity ratio of 120.38, a current ratio of 1.39 and a quick ratio of 2.32. The company has a fifty day moving average price of C$3.72 and a 200-day moving average price of C$5.84.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Recommended Stories

Analyst Recommendations for Canopy Growth (TSE:WEED)

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a "Strong Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Goldman Sachs' 2025 Market Outlook: Top 3 Stock Picks

Goldman Sachs' 2025 Market Outlook: Top 3 Stock Picks

As Wall Street's 2025 predictions roll in, Goldman Sachs is focusing on manufacturing, energy, and domestic producers as key sectors for growth.

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines